Leti and EPFL Expand R&D Partnership with Monthly Seminars on Micro- and Nanotechnology Topics
News May 07, 2009
Leti and Ecole Polytechnique Fédérale de Lausanne (EPFL) have begun a monthly seminar series for students and professionals to discuss technical issues facing micro- and nanotechnology researchers.
Designed to supplement their recent R&D agreement, the series will focus on such topics as fabrication and design of nanometer-scale regular circuits, 3D integration, brain-computer interface and beyond CMOS. The collaboration is designed to attract students and post-doctorate researchers for “common subjects” at both organizations.
The next two seminars are:
• "Design Technologies for 3D Integration," Dr. Vasileios Pavlidis, May 29 at Leti
• "Lab-on-Chip for Cancer Diagnosis," Dr. Pierre Grangeat, July 2 at EPFL
“Leti and EPFL have many complementary programs and strengths that can benefit both organizations,” said Marie-Noëlle Séméria, Leti’s vice president for strategy and international business development. “Leti’s research projects and state-of-the-art platforms offer unique R&D opportunities for EPFL researchers and post-doctorate engineers. EPFL has an international reputation as a leading engineering school that also is focused on creating innovation, technology transfer and working with start-ups. EPFL is a strategic partner for Leti”.
“In addition to research programs that are aimed at bringing new micro- and nanotechnology capabilities to the market, EPFL has a long tradition of partnering with companies and research centers,” said Giovanni De Michelli, director of the Institute of Electrical Engineering at EPFL. “This collaboration with Leti offers EPFL engineers and researchers the opportunities to continue their work on innovation and technology transfer with established, international companies.”
Have you ever been stressed out by the idea of doing math or statistics problems? You’re not alone. A new study has used a questionnaire and an analytical technique called "network science" to determine precisely what factors contribute to this kind of statistics anxiety among psychology majors.
Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.READ MORE
Anxiety and depression are surprisingly common among young children. But it can be hard to detect these conditions, known as “internalizing disorders,” because the symptoms are so inward-facing that parents, teachers and doctors often fail to notice them. Now, researchers have developed a tool that could help screen children for internalizing disorders to catch them early enough to be treated.
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019